These findings detail a novel excitatory action of CBD at vagal afferent neurons which requires TRPA1 and may contribute to the vagal mimetic effects of CBD and adaptation following chronic cannabis use.
These findings detail a novel excitatory action of CBD at vagal afferent neurons which requires TRPA1 and may contribute to the vagal mimetic effects of CBD and adaptation following chronic cannabis use.
Date: 09/01/20
URL: https://pubmed.ncbi.nlm.nih.gov/32965166/
Tags: cannabis | CBD | nodose ganglia | transient receptor potential | vagus
Contact details
LAYV B.V.
Panamalaan 2G
1019 AZ Amsterdam
📍LAYV CBD
hey@layv.co
Chamber of Commerce: 72846461
VAT: NL859258555B01
Products
© 2023 LAYV B.V.